Matthew Hamilton Rosenberg’s Zimmer Biomet ZBH Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-20	Closed	-$1.82K	–	838
2025 Q2	$1.82K	Buy	+20	New	+$1.93K	﹤0.01%	783
2024 Q4	–	Sell	-380	Closed	-$40.8K	–	871
2024 Q3	$41K	Hold	380	–	–	0.01%	459
2024 Q2	$40.3K	Hold	380	–	–	0.01%	455
2024 Q1	$49.3K	Hold	380	–	–	0.01%	435
2023 Q4	$46.2K	Sell	380 -100	-21%	-$11.2K	0.01%	442
2023 Q3	$53.9K	Hold	480	–	–	0.02%	402
2023 Q2	$69.9K	Hold	480	–	–	0.02%	373
2023 Q1	$62K	Hold	480	–	–	0.02%	419
2022 Q4	$61.2K	Hold	480	–	–	0.02%	412
2022 Q3	$50K	Hold	480	–	–	0.02%	438
2022 Q2	$51K	Hold	480	–	–	0.02%	451
2022 Q1	$61K	Sell	480 -14	-3%	-$1.69K	0.02%	414
2021 Q4	$31K	Hold	494	–	–	0.01%	484
2021 Q3	$70K	Hold	494	–	–	0.03%	343
2021 Q2	$77K	Hold	494	–	–	0.04%	302
2021 Q1	$77K	Hold	494	–	–	0.04%	291
2020 Q4	$74K	Buy	494 +103	+26%	+$14.5K	0.05%	277
2020 Q3	$52K	Hold	391	–	–	0.04%	305
2020 Q2	$45K	Buy	+391	New	+$45.1K	0.04%	320

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Matthew Hamilton Rosenberg's ZBH Position: Q3 2025 in Review

Matthew Hamilton Rosenberg sold out of Zimmer Biomet (ZBH) in Q3 2025, closing a stake of 20 shares — an estimated $1.82K sold.

Matthew Hamilton Rosenberg first reported a position in ZBH in Q2 2020 and held it in 19 quarters. The position peaked at $77K in Q2 2021. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.

Matthew Hamilton Rosenberg reported no remaining Zimmer Biomet position as of Q3 2025 after selling out during the quarter.
Matthew Hamilton Rosenberg sold 20 Zimmer Biomet shares in Q3 2025, an estimated $1.82K.
Matthew Hamilton Rosenberg first reported a position in Zimmer Biomet in Q2 2020 and held it in 19 quarters.
Matthew Hamilton Rosenberg's Zimmer Biomet position peaked at $77K in Q2 2021.
966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.

Based on Matthew Hamilton Rosenberg's 13F filing for Q3 2025, filed 10 Nov 2025.